Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shu Fang, Zhehai Wang, Jun Guo, Jie Liu, Changzheng Li, Lin Liu, Huan Shi, Liyan Liu, Huihui Li, Chao Xie, Xia Zhang, Wenwen Sun & Minmin Li. (2014) Correlation between EGFR mutation status and response to first-line platinum-based chemotherapy in patients with advanced non-small cell lung cancer. OncoTargets and Therapy 7, pages 1185-1193.
Read now
Read now
Anna De Geer, Jennifer Eriksson & Henrik W. Finnern. (2013) A cross-country review of data collected on non-small cell lung cancer (NSCLC) patients in cancer registries, databases, retrospective and non-randomized prospective studies. Journal of Medical Economics 16:1, pages 134-149.
Read now
Read now
Alain Vergnenegre, Egbert F. Smit, Elisabeth Toy, Barbara Parente, Stephan Schmitz, Kees Kraaij, Victoria Soldatenkova, Carla Visseren-Grul, Giovanni Zanotti, Kaisa Taipale & Denis Moro-Sibilot. (2012) Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study. Current Medical Research and Opinion 28:8, pages 1253-1262.
Read now
Read now
Articles from other publishers (12)
Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, Hiroshi Isobe, Ming-Shyan Huang, Carlos H. Barrios, Adnan Khattak, Filippo de Marinis, Smita Kothari, Ashwini Arunachalam, Xiting Cao, Thomas Burke, Amparo Valladares & Javier de Castro. (2018) Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study. PLOS ONE 13:8, pages e0202865.
Crossref
Crossref
J. de Castro, P. Tagliaferri, V.C.C. de Lima, S. Ng, M. Thomas, A. Arunachalam, X. Cao, S. Kothari, T. Burke, H. Myeong, A. Grattan & D.H. Lee. (2017) Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study. European Journal of Cancer Care 26:6, pages e12734.
Crossref
Crossref
Jessica Davies, Manali Patel, Cesare Gridelli, Filippo de Marinis, Daniel Waterkamp & Margaret E. McCusker. (2017) Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies. PLOS ONE 12:4, pages e0175679.
Crossref
Crossref
Nicolas Girard, Jesus Corral, Diego Cortinovis & David F. Heigener. (2017) Second-Line Treatment Selection in Patients With Non–Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians. Clinical Lung Cancer 18:2, pages e89-e97.
Crossref
Crossref
Janna Afanasjeva, Rita L. Hui, Michele M. Spence, Jennifer Chang, Joanne E. Schottinger, Mirta Millares & Nazia Rashid. (2016) Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:10, pages 1065-1074.
Crossref
Crossref
Sun Min Lim, Byeong Bae Park, Keun‐Chil Park, Hoon‐Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung‐Sei Lee, Jin‐Hyoung Kang, Se‐Hoon Park, Gyeong‐Won Lee, Hyo‐Rac Lee, Jae Hong Seo, Yong Tae Kim, Sung Hyun Yang & Joo‐Hang Kim. (2015)
Safety and efficacy of single‐agent docetaxel (
T
axotere) administered weekly in non‐small cell lung carcinoma patients in
K
orea: An observational study
. Thoracic Cancer 7:2, pages 207-214.
Crossref
Crossref
Cesare Gridelli, Filippo de Marinis, Andrea Ardizzoni, Silvia Novello, Gabriella Fontanini, Federico Cappuzzo, Francesco Grossi, Antonio Santo, Diego Cortinovis, Adolfo Favaretto, Vito Lorusso, Domenico Galetta, Salvatore Siena, Anna Bettini, Monica Iurlaro & Alberto Caprioli. (2014) Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study. Journal of Cancer Research and Clinical Oncology 140:10, pages 1783-1793.
Crossref
Crossref
Wa Cao, Ai-Wu Li, Sheng-Xiang Ren, Xiao-Xia Chen, Wei Li, Guang-Hui Gao, Ya-Yi He & Cai-Cun Zhou. (2014) Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention 15:16, pages 6799-6804.
Crossref
Crossref
Arijit Ganguli, Phillip Wiegand, Xin Gao, John A. Carter, Marc F. Botteman & Saurabh Ray. (2012) The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review. Quality of Life Research 22:5, pages 1015-1026.
Crossref
Crossref
Riad Naim Younes, José Rodrigues Pereira, Abdo Latif Fares & JeffersonLuiz Gross. (2011) Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer. Revista da Associação Médica Brasileira 57:6, pages 686-691.
Crossref
Crossref
Riad Naim Younes, José Rodrigues Pereira, Abdo Latif Fares & JeffersonLuiz Gross. (2011) Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer. Revista da Associação Médica Brasileira (English Edition) 57:6, pages 672-677.
Crossref
Crossref
Riad Naim Younes, José Rodrigues Pereira, Abdo Latif Fares & JeffersonLuiz Gross. (2011) Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer. Revista da Associação Médica Brasileira 57:6, pages 672-677.
Crossref
Crossref